본문으로 건너뛰기
← 뒤로

Multi-therapies in androgenetic alopecia: review and clinical experiences.

4/5 보강
Dermatologic therapy 📖 저널 OA 54.7% 2021: 45/77 OA 2022: 47/93 OA 2021~2022 2016 Vol.29(6) p. 424-432 피인용 29회 cited 128 OA RCR 3.74 Hair Growth and Disorders
TL;DR The treatment for AGA should be based on personalized therapy and targeted at the different pathophysiological aspects of AGA, since the benefit will not be maintained upon ceasing therapy.
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-05-08
📑 코퍼스 인용 관계 · 인용됨 29
📑 인용한 논문 (6) ▾
연도별 인용 (2017–2026) · 합계 128
OpenAlex 토픽 · Hair Growth and Disorders

Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G

📖 무료 전문 🔓 OA PDF oa

관련 도메인

↔ 함께 자주 등장하는 논문 6 — 같은 위키 또는 NER 엔티티 공유
📝 환자 설명용 한 줄

The treatment for AGA should be based on personalized therapy and targeted at the different pathophysiological aspects of AGA, since the benefit will not be maintained upon ceasing therapy.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Alfredo Rossi, Alessia Anzalone, et al. (2016). Multi-therapies in androgenetic alopecia: review and clinical experiences.. Dermatologic therapy, 29(6), 424-432. https://doi.org/10.1111/dth.12390
MLA Alfredo Rossi, et al.. "Multi-therapies in androgenetic alopecia: review and clinical experiences.." Dermatologic therapy, vol. 29, no. 6, 2016, pp. 424-432.
PMID 27424565 ↗
DOI 10.1111/dth.12390

Abstract

Androgenetic alopecia (AGA) is a genetically determined progressive hair-loss condition which represents the most common cause of hair loss in men. The use of the medical term androgenetic alopecia reflects current knowledge about the important role of androgens and genetic factors in its etiology. In addition to androgen-dependent changes in the hair cycle, sustained microscopic follicular inflammation contributes to its onset. Furthermore, Prostaglandins have been demonstrated to have the ability in modulating hair follicle cycle; in particular, PGD2 inhibits hair growth while PGE2/F2a promote growth. Due to the progressive nature of AGA, the treatment should be started early and continued indefinitely, since the benefit will not be maintained upon ceasing therapy. To date, only two therapeutic agents have been approved by the Food and Drug Administration and European Medicines Agency for the treatment of AGA: topical minoxidil and oral finasteride. Considering the many pathogenetic mechanisms involved in AGA, various treatment options are available: topical and systemic drugs may be used and the choice depends on various factors including grading of AGA, patients' pathological conditions, practicability, costs and risks. So, the treatment for AGA should be based on personalized therapy and targeted at the different pathophysiological aspects of AGA.

추출된 의학 개체 (NER)

전체 NER 표 보기
유형영어 표현한국어 / 풀이UMLS CUI출처등장
질환 androgenetic alopecia 안드로겐성 탈모 dict 3
질환 androgenetic alopecia 안드로겐성 탈모 dict 3
질환 androgenetic alopecia 안드로겐성 탈모 dict 3
해부 hair follicle 모낭 dict 1
해부 hair follicle 모낭 dict 1
해부 hair follicle 모낭 dict 1
약물 minoxidil 미녹시딜 dict 1
약물 minoxidil 미녹시딜 dict 1
약물 finasteride 피나스테리드 dict 1
약물 finasteride 피나스테리드 dict 1
약물 minoxidil 미녹시딜 dict 1
약물 finasteride 피나스테리드 dict 1

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

인용 관계

그래프 OA 노드: 6/8 (75%) · 참조 0편 · 후속 6편

이 논문을 인용한 후속 연구 20

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능

🔓 OA PDF 열기